...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Cerebrospinal fluid bioavailability and pharmacokinetics of bupivacaine and lidocaine after intrathecal and epidural administrations in rabbits using microdialysis.
【24h】

Cerebrospinal fluid bioavailability and pharmacokinetics of bupivacaine and lidocaine after intrathecal and epidural administrations in rabbits using microdialysis.

机译:使用微透析对兔进行鞘内和硬膜外给药后布比卡因和利多卡因的脑脊液生物利用度和药代动力学。

获取原文
获取原文并翻译 | 示例

摘要

The aim of this work was to study the cerebrospinal fluid (CSF) bioavailability and pharmacokinetics of bupivacaine (BUP) and lidocaine (LID) administered separately in rabbits using microdialysis with retrodialysis calibration. Microdialysis probe and catheters were inserted under control of the view in the intrathecal or epidural spaces. The epidural disposition of BUP and LID after epidural administration of low (0.69 microM) and high (6.9 microM) doses was studied. Then, the intrathecal and plasma dispositions after separate intrathecal (0.2 microM) and epidural administration (6.9 microM) were investigated. The CSF binding of BUP and LID was linear in a range from 50 to 500 micrograms/ml, and the mean unbound CSF fraction at a concentration of 100 micrograms/ml was 39. 3 +/- 2.3% for BUP and 75.8 +/- 7.7% for LID. Epidural and intrathecal disposition of BUP and LID showed a biexponential decline. After epidural administration, the CSF concentrations of BUP and LID were much higher than those in plasma. After intrathecal administration, the plasma concentrations were below the limit of quantitation. Although the absorption rate of BUP appeared higher than that of LID, the mean CSF bioavailability of epidural BUP and LID was 5.5 and 17.7%, respectively. The unexpectedly higher CSF bioavailability of LID, the less lipophilic drug, may result from the difference in the processes competing for drug epidural removal.
机译:这项工作的目的是研究使用微透析和逆渗透析校正剂分别对兔中布比卡因(BUP)和利多卡因(LID)的脑脊液(CSF)的生物利用度和药代动力学。将微透析探针和导管在视野控制下插入鞘内或硬膜外腔。研究了硬膜外给药低剂量(0.69 microM)和高剂量(6.9 microM)后BUP和LID的硬膜外处置。然后,研究了分别进行鞘内注射(0.2 microM)和硬膜外给药(6.9 microM)后的鞘内和血浆配置。 BUP和LID的CSF结合在50到500微克/毫升的范围内呈线性关系,在100微克/毫升的浓度下,未结合的CSF平均分数为39. BUP的3 +/- 2.3%和75.8 +/- LID为7.7%。 BUP和LID的硬膜外和鞘内处置显示双指数下降。硬膜外给药后,BUP和LID的脑脊液浓度远高于血浆。鞘内给药后,血浆浓度低于定量限。尽管BUP的吸收率似乎高于LID,但硬膜外BUP和LID的平均CSF生物利用度分别为5.5和17.7%。 LID(亲脂性药物较少)的CSF出乎意料的更高的生物利用度可能是由于竞争性硬膜外去除过程的差异所致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号